Patient or carer satisfaction with information provided CCFNI (between day 3 and day 5); scale from 14 to 56 Lower scores indicate increased satisfaction. FS‐ICU 24 (90 days after randomisation); scale from 0 to 100 Lower scores indicate less sati... · adult ICU patients and their carers
1 finding from 1 review
Intervention not reported
Discharge to an increased level of care · Improving outcomes in older adult people admitted to a surgical service.
The intervention leads to lower discharge to an increased level of care (high certainty).
1 finding from 1 review
RR 0.71 [0.55, 0.92]
941 participants
High
AE: Serum creatinine increase · people with transfusion‐dependent thalassemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drug‐related AE: serum creatinine increased (≥ 33%) above baseline in 2 consecutive occasions · people with transfusion‐dependent thalassemia
It is very uncertain whether deferasirox and deferiprone changes drug‐related AE: serum creatinine increased (≥ 33%) above baseline… compared with deferiprone and deferoxamine (very low certainty).
1 finding from 1 review
Maternal level of confidence in breastfeeding · healthy breastfeeding full‐term infants
1 finding from 1 review
Number of participants with increased pain after 4 weeks · patients with pain in Guillain‐Barré syndrome
Methylprednisolone showed no clear difference in number of participants with increased pain after 4 weeks compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Knowledge among participants of vaccine or vaccine‐preventable disease (number of people whose vaccine knowledge had increased;
1 finding from 1 review
no estimate extracted
55821 participants
Low
Weight gain · patients with schizophrenia
Bromperidol decanoate showed no clear difference in adverse effects ‐ increased weight compared with placebo (low certainty).
1 finding from 1 review
No clinically important change Number of people whose PANSS score either increased or did not decrease by at least 30% from the beginning to the end of the trial · patients with schizophrenia
Paliperidone palmitate showed no clear difference in no clinically important change Number of people whose PANSS score… compared with risperidone long‐acting injection (low certainty).
1 finding from 1 review
No clinically important change Number of people whose PANSS score either increased or did not decrease by at least 30% from the beginning to the end of the trial · patients with schizophrenia
Paliperidone palmitate probably leads to lower no clinically important change Number of people whose PANSS score… compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Need for increased ventilatory assistance (invasive or non‐invasive) · individuals with an exacerbation of COPD
The intervention may leads to lower need for increased ventilatory assistance (invasive or non‐invasive) (low certainty).
1 finding from 1 review
Intervention not reported
Number of participants with increased cough · patients with prolonged non‐specific cough in children
The intervention showed no clear difference in number of participants with increased cough (moderate certainty).
1 finding from 1 review
Increased salivation · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
Any CNTF showed no clear difference in increased salivation compared with placebo (high certainty).
1 finding from 1 review
Low birthweight · women at increased risk of low birthweight babies (maternal outcomes)
Additional support showed no clear difference in birthweight < 2500 g compared with usual care during pregnancy (moderate certainty).
1 finding from 1 review
Satisfaction with pregnancy care Pregnancy care rated as "very helpful" · women at increased risk of low birthweight babies (maternal outcomes)
Additional support probably leads to higher satisfaction with pregnancy care Pregnancy care rated as "very… compared with usual care during pregnancy (moderate certainty).
1 finding from 1 review
Gestational age (preterm birth < 37 weeks) · women at increased risk of low birthweight babies (maternal outcomes)
Additional support showed no clear difference in gestational age < 37 weeks at birth compared with usual care during pregnancy (moderate certainty).
1 finding from 1 review
Death of a baby (stillbirth or neonatal death) report of perinatal death · women at increased risk of low birthweight babies (maternal outcomes)
Additional support showed no clear difference in stillbirth/neonatal death compared with usual care during pregnancy (low certainty).
1 finding from 1 review
Assessment of long‐term morbidity · women at increased risk of low birthweight babies (maternal outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caesarean section · women at increased risk of low birthweight babies (maternal outcomes)
Additional support probably leads to lower caesarean section compared with usual care during pregnancy (moderate certainty).
1 finding from 1 review
Number of antenatal hospital admissions · women at increased risk of low birthweight babies (maternal outcomes)
Additional support probably leads to lower antenatal hospital admissions Number of admissions per woman compared with usual care during pregnancy (moderate certainty).
2 findings from 1 review